Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : GLAXF save search
Europe Frontotemporal Dementia Market Research Report 2023: Growing Prevalence of Dementia & Increasing Number of Clinical Trials - Competition, Forecasts & Opportunities to 2028
Published: 2023-04-26 (Crawled : 15:20) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: -4.57%
H: 0.22%
C: -1.98%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.46%
H: 0.0%
C: 0.0%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
VTRS A | $11.25 1.17% 1.16% 4.7M
|
Health Technology
|
| O: 0.22%
H: 0.65%
C: -1.09%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.62%
H: 0.0%
C: -2.04%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.66%
H: 0.18%
C: -0.9%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.03%
H: 0.3%
C: -2.63%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.53%
H: 0.0%
C: 0.0%
CNTG | $0.463 0.43% 0.43% 79K
|
Commercial Services
|
| O: 1.23%
H: 27.27%
C: -15.76%
europe report dementia trials research growing market
Fulcrum Therapeutics Announces Second Quarter 2022 Financial Results and Business Update
Published: 2022-08-11 (Crawled : 12:00) - biospace.com/
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: -12.81%
H: 8.43%
C: 5.21%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -8.67%
H: 2.89%
C: 2.14%
FULC | $6.86 -2.83% -2.92% 560K
|
Health Technology
|
| O: -10.82%
H: 17.27%
C: 9.39%
therapeutics update results
Anxious World Waits As Covid Vaccine Makers Address Omicron Variant
Published: 2021-12-07 (Crawled : 14:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 5.22%
H: 0.0%
C: -1.25%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 2.13%
H: 0.0%
C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.14%
H: 0.0%
C: 0.0%
VIR | $7.96 0.0% 1.1M
|
Health Technology
|
| O: -6.42%
H: 8.6%
C: 8.45%
SRNE | $0.024 -8.85% 57K
|
Health Technology
|
| O: 6.57%
H: 14.77%
C: 11.21%
RDHL | $0.4519 7.39% 6.88% 330K
|
Health Technology
|
| O: 0.37%
H: 10.37%
C: 9.63%
covid vaccine
Anti-obesity Drugs Market Size to Grow by USD 454.51 million | Growing Obese Population to Boost Market Growth | 17,000+ Technavio Research Reports
Published: 2022-07-06 (Crawled : 15:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: -0.73%
H: 1.02%
C: 1.02%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.51%
H: 0.73%
C: 0.07%
BHC | $8.69 1.05% 0.0% 2.9M
|
Health Technology
|
| O: -0.77%
H: 1.61%
C: -4.45%
RYTM A | $37.975 -0.35% -0.36% 620K
|
Health Technology
|
| O: 0.45%
H: 8.37%
C: 7.24%
research growing growth market obesity
Zentalis Announces Preclinical Data Supporting Cyclin E1 As A Predictive Marker For Azenosertib Treatment At AACR Annual Meeting 2023
Published: 2023-04-17 (Crawled : 14:00) - biospace.com/
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 0.88%
H: 3.85%
C: 3.85%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.24%
H: 0.01%
C: -0.77%
ZNTL | $12.97 3.43% 3.32% 1M
|
Health Technology
|
| O: 1.54%
H: 8.37%
C: 5.89%
treatment preclinical meeting
Cullinan Oncology Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results
Published: 2022-03-17 (Crawled : 12:00) - biospace.com/
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: -1.77%
H: 0.0%
C: -3.55%
CGEM | $15.66 -13.29% -15.33% 1.2M
|
|
| O: -2.53%
H: 7.62%
C: 7.29%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.6%
H: 2.92%
C: 2.21%
financial results report results
Cellular Immunotherapy Market Research Report by Type, Indication, Technology Type, End Use, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
Published: 2022-11-10 (Crawled : 17:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: -0.06%
H: 0.0%
C: 0.0%
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: 6.22%
H: 3.13%
C: -0.56%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 2.81%
H: 0.43%
C: -0.2%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.18%
H: 0.0%
C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 2.59%
H: 0.72%
C: 0.63%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 1.22%
H: 0.01%
C: -1.7%
IOVA | News M | $11.32 -3.41% -3.53% 5.3M
|
Health Technology
|
| O: 6.12%
H: 4.99%
C: 4.21%
INO 4 d | $9.68 -5.1% -5.37% 350K
|
Health Technology
|
| O: 5.5%
H: 4.35%
C: 3.48%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 1.43%
H: 0.36%
C: -1.08%
ATRA | $0.6755 -2.34% -2.4% 1.6M
|
Health Technology
|
| O: 2.58%
H: 23.12%
C: 20.85%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 7.08%
H: 0.84%
C: -0.43%
ADAP | $0.97 7.97% 7.38% 1.5M
|
Health Technology
|
| O: 0.0%
H: 7.14%
C: 5.71%
covid-19 research global immunotherapy report impact technology market
Global Lupus Therapeutic Market to Surpass US$ 5,408.1 Million by 2030, Says Coherent Market Insights
Published: 2022-03-16 (Crawled : 18:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: -0.46%
H: 3.49%
C: 3.49%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 2.25%
H: 0.0%
C: 0.0%
UCBJY | $63.676 -4.38% 7.2K
|
Manufacturing
|
| O: 1.41%
H: 2.33%
C: 0.04%
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: 2.07%
H: 1.62%
C: 1.56%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.74%
H: 0.0%
C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.41%
H: 0.0%
C: 0.0%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 0.26%
H: 0.31%
C: -0.39%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
AUPH | $5.01 4.16% 3.99% 1.6M
|
Health Technology
|
| O: 0.95%
H: 6.23%
C: 5.19%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.41%
H: 0.0%
C: -0.37%
lupus market
$12+ Billion Influenza Vaccines Market to Grow at 7+% CAGR, Globally, by 2028 Lead by Quadrivalent Vaccines Segment with 88.36% Market Share in 2022 | The Insight Partners
Published: 2022-10-28 (Crawled : 11:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 3.33%
H: 0.74%
C: -1.67%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.89%
H: 1.3%
C: 0.79%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 2.57%
H: 0.0%
C: 0.0%
MRNA S | $101.44 -0.55% -0.55% 2.6M
|
Health Technology
|
| O: -0.88%
H: 5.85%
C: 5.69%
influenza market vaccine
CureVac veröffentlicht in „Nature” präklinische Daten des COVID-19-Kandidaten der zweiten Generation, CV2CoV, die vergleichbaren Antikörperspiegel wie bei lizenziertem mRNA-Impfstoff nachweisen
Published: 2021-11-18 (Crawled : 11:00) - curevac.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: -6.25%
H: 3.09%
C: -0.45%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -1.66%
H: 0.24%
C: -0.12%
CVAC | $2.44 0.0% 790K
|
Health Technology
|
| O: 8.03%
H: 4.75%
C: 2.8%
covid cv2cov
Radius Files Definitive Proxy and Mails Letter to Stockholders
Published: 2022-06-06 (Crawled : 12:00) - ir.radiuspharm.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 6.14%
H: 0.0%
C: -1.39%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.09%
H: 0.0%
C: -0.93%
RDUS | $18.41 -0.61% -0.61% 220K
|
Health Technology
|
| O: 1.01%
H: 4.6%
C: 0.92%
Zentalis Pharmaceuticals Reports First Quarter 2023 Financial Results and Operational Updates
Published: 2023-05-10 (Crawled : 11:00) - globenewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: -1.66%
H: 0.0%
C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.03%
H: 0.38%
C: 0.25%
ZNTL | $12.97 3.43% 3.32% 1M
|
Health Technology
|
| O: 2.59%
H: 4.49%
C: 4.23%
pharmaceuticals financial results
GSK and Vir Biotechnology Announce United States Government Agreements to Purchase Sotrovimab, a COVID-19 Treatment
Published: 2021-11-17 (Crawled : 12:00) - globenewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 1.43%
H: 2.31%
C: 2.27%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.28%
H: 0.0%
C: 0.0%
VIR | $7.96 0.0% 1.1M
|
Health Technology
|
| O: 9.97%
H: 4.0%
C: -6.28%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.06%
H: 0.0%
C: 0.0%
covid treatment biotech technology iot covid-19
CureVac von LexisNexis® als einer der weltweit dynamischsten Innovatoren ausgezeichnet
Published: 2023-01-31 (Crawled : 13:20) - curevac.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 2.04%
H: 0.0%
C: -3.67%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.85%
H: 0.31%
C: -0.45%
CVAC | $2.44 0.0% 790K
|
Health Technology
|
| O: -1.73%
H: 3.25%
C: -5.62%
lexisnexis als
CureVac reicht in Deutschland Klage gegen BioNTech wegen Patentrechtsverletzung ein
Published: 2022-07-05 (Crawled : 11:00) - curevac.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: -0.47%
H: 2.26%
C: -1.71%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -1.33%
H: 0.36%
C: 0.3%
CVAC | $2.44 0.0% 790K
|
Health Technology
|
| O: 0.39%
H: 3.11%
C: -1.43%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: -3.89%
H: 7.56%
C: 6.38%
Dementia and Movement Disorder Treatment Market: 45% of Growth to Originate from North America | By Drug Class and Geography - Forecast and Analysis 2022-2026
Published: 2022-05-11 (Crawled : 01:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.81%
H: 0.0%
C: -0.09%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.27%
H: 1.2%
C: -0.85%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.65%
H: 1.14%
C: -1.14%
BHC | $8.69 1.05% 0.0% 2.9M
|
Health Technology
|
| O: 15.69%
H: 13.62%
C: 9.04%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.21%
H: 0.0%
C: 0.0%
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: -0.15%
H: 3.04%
C: -0.63%
america treatment dementia drug growth
CureVac veröffentlicht Finanzergebnisse für das dritte Quartal sowie die ersten neun Monate 2021 und informiert über das laufende Geschäft
Published: 2021-11-18 (Crawled : 22:00) - curevac.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 1.55%
H: 0.0%
C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.75%
H: 0.12%
C: -0.53%
CVAC | $2.44 0.0% 790K
|
Health Technology
|
| O: -0.29%
H: 3.03%
C: 0.34%
Worldwide T-cell Lymphoma Industry to 2028 - Featuring Genmab, Seagen and GlaxoSmithKline Among Others
Published: 2022-04-28 (Crawled : 21:00) - prnewswire.com
GNMSF | $290.38 3.83% 220
|
Health Technology
|
| O: 2.93%
H: 1.47%
C: 1.33%
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: -0.45%
H: 0.0%
C: 0.0%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -1.05%
H: 0.0%
C: -0.99%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.19%
H: 0.59%
C: -1.36%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.89%
H: 0.0%
C: 0.0%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: -3.61%
H: 3.02%
C: 2.02%
BHC | $8.69 1.05% 0.0% 2.9M
|
Health Technology
|
| O: -1.67%
H: 0.0%
C: 0.0%
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
|
| O: 1.4%
H: 0.82%
C: -1.07%
t-cell
Bronchitis Treatment Market Size to Grow by USD 1.12 bn | Technavio
Published: 2022-03-17 (Crawled : 02:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: -1.77%
H: 0.0%
C: -3.55%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.62%
H: 0.0%
C: 0.0%
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: 2.2%
H: 3.15%
C: 0.06%
VTRS A | $11.25 1.17% 1.16% 4.7M
|
Health Technology
|
| O: -1.25%
H: 4.68%
C: 3.7%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.08%
H: 0.0%
C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.6%
H: 2.92%
C: 2.21%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.17%
H: 0.0%
C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 0.34%
H: 2.89%
C: 2.51%
treatment
Respiratory Inhalers Market is Expected to Escalate at a CAGR of 5.38% and Reach USD 47.83 Billion by 2026, Analyzes DelveInsight
Published: 2022-03-17 (Crawled : 16:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: -1.77%
H: 0.0%
C: -3.55%
TFX | $206.56 -0.4% 0.0% 420K
|
Health Technology
|
| O: -0.23%
H: 2.66%
C: 1.97%
SYK | $325.43 -0.62% 0.0% 1.8M
|
Health Technology
|
| O: 0.43%
H: 2.1%
C: 2.1%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.08%
H: 0.0%
C: 0.0%
MDT | $79.48 0.37% -0.29% 6.7M
|
Health Technology
|
| O: -0.19%
H: 0.0%
C: 0.0%
PHG | $19.98 0.0% 540K
|
Health Technology
|
| O: -2.96%
H: 1.35%
C: 0.74%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.6%
H: 2.92%
C: 2.21%
BDX | $234.12 0.42% 0.0% 1.3M
|
Health Technology
|
| O: 0.11%
H: 0.0%
C: 0.0%
INVA | $14.955 1.8% 1.77% 640K
|
Health Technology
|
| O: 0.16%
H: 3.66%
C: 3.6%
respiratory
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
GBR | $1.42 31.48% 11.27% 990K
|
Energy Minerals
DEO | News | $140.76 -0.02% 8.27% 560K
|
Consumer Non-Durables
KUKE | $2.88 2.49% 7.64% 360K
|
SYY | $76.73 1.44% 5.49% 2.5M
|
Distribution Services
TWI | $11.53 0.96% 4.94% 330K
|
Producer Manufacturing
BTCM | $1.99 -6.13% 4.52% 75K
|
Arts, Entertainment, and Recrea...
MPLN | $0.6502 -11.74% 4.51% 2.2M
|
Finance
CXM 4 | $11.34 -0.44% 4.27% 1.7M
|
Information
UHS | $157.47 2.49% 4.13% 900K
|
Health Services
Your saved searches
Save your searches and get alerts when important news are released.